The future of cystic fibrosis can be different thanks to personalized medicine
Researchers are growing mini gut and lung “avatars” derived from cells of children with cystic fibrosis.
Patients’ stem cells are collected at 11 CF clinics across Australia.
Stem cells are grown into miniature versions of the gut and lung.
Mini-organs are then frozen and preserved in the ECF biobank for future testing.
ECF AVATAR platform uses patient-derived mini-organs to assess the best medication for each patient.
Research is done by the University of New South Wales.